In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Sepracor and Lilly's Prozac NCE deal terminated

Executive Summary

Eli Lilly has agreed to pay up to $90mm--(uf)$20mm up front and $70mm in milestone payments--plus royalties (based on a progressive scale that will reach double digits only after a high level of sales) for Sepracor's purified version of Prozac.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Chiral Chemistry
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Includes Contract
    • Marketing (Licensing)

Related Companies